Humanwell Healthcare (Group) Co.,Ltd. (SHA:600079)
22.02
-0.01 (-0.05%)
Sep 12, 2025, 2:45 PM CST
SHA:600079 Revenue
Humanwell Healthcare (Group) had revenue of 5.93B CNY in the quarter ending June 30, 2025, a decrease of -8.74%. This brings the company's revenue in the last twelve months to 24.64B, down -1.46% year-over-year. In the year 2024, Humanwell Healthcare (Group) had annual revenue of 25.44B with 3.71% growth.
Revenue (ttm)
24.64B
Revenue Growth
-1.46%
P/S Ratio
1.46
Revenue / Employee
1.40M
Employees
17,650
Market Cap
35.97B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 25.44B | 910.74M | 3.71% |
Dec 31, 2023 | 24.52B | 2.19B | 9.79% |
Dec 31, 2022 | 22.34B | 1.79B | 8.71% |
Dec 31, 2021 | 20.55B | -131.18M | -0.63% |
Dec 31, 2020 | 20.68B | -1.13B | -5.17% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 30.15B |
WuXi AppTec | 41.90B |
Shenzhen Mindray Bio-Medical Electronics | 32.94B |
Sichuan Biokin Pharmaceutical | 441.19M |
Shanghai United Imaging Healthcare | 10.98B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.52B |
Aier Eye Hospital Group | 21.94B |
Yunnan Baiyao Group Co.,Ltd | 40.84B |